Login / Signup

Cancer surveillance for transgender and gender diverse patients with Lynch syndrome: a practice resource of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.

Rachel HodanLinda H Rodgers-FoucheAnu ChittendenMev Dominguez-ValentinJames Stuart FerrissLauren GimaOle-Petter Riksfjord HamnvikGregory E IdosKevin KlineDiane R KoellerKatherine L NathansonDanielle McKennaCharles MullerMaxton ThomanAnton WintnerBronwyn S Bedricknull null
Published in: Familial cancer (2023)
Transgender and gender diverse (TGD) populations with hereditary cancer syndromes face unique obstacles to identifying and obtaining appropriate cancer surveillance and risk-reducing procedures. There is a lack of care provider knowledge about TGD health management. Lynch syndrome (LS) is one of the most common hereditary cancer syndromes, affecting an estimated 1 in 279 individuals. There are no clinical guidelines specific for TGD individuals with LS, highlighting a need to improve the quality of care for this population. There is an urgent need for cancer surveillance recommendations for TGD patients. This commentary provides recommendations for cancer surveillance, risk-reducing strategies, and genetic counseling considerations for TGD patients with LS.
Keyphrases